Company Overview of Ocularis Pharma, Inc.
Key Executives for Ocularis Pharma, Inc.
|Alan R. Meyer||No Relationships||Founder and Chief Executive Officer||63|
|Gerald Horn M.D.||No Relationships||Founder and Chief Scientific Officer||--|
|Keith D. Terry||No Relationships||Founder and Senior Vice President of Commercial & Business Development||--|
Ocularis Pharma, Inc. Board Members*
|Name||Board Relationships||Primary Company||Age|
|Glen Bradley||34 Relationships||Refocus Group Inc.||74|
|Peter F. Drake Ph.D.||38 Relationships||Vector Securities, L.L.C.||63|
|Wilbur Henry Gantz III||119 Relationships||PathoCapital||79|
|Stephen D. Klyce Ph.D.||26 Relationships||Ocularis Pharma, Inc.||--|
|Robert J. Lepkowski||5 Relationships||Ocularis Pharma, Inc.||--|
Ocularis Pharma, Inc. Executive Committees*
|Committee Name||Chairperson||Board Relationships||Members|
|There is no committee data available.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
CEO COMPENSATION IN THIS INDUSTRY
|Total Short Term Compensation|
|Total Value of Options|
INDUSTRY EXECUTIVE CHANGES
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.